FDA Inspection 1308272 — Elucid Bioimaging Inc.
The FDA completed an inspection of Elucid Bioimaging Inc. on Mar 20, 2026 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 20, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Boston, MA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 23214 | ISO 13485:2016 Clause 8.2.2 | Complaint handling procedures not documented |